thiazolidines has been researched along with Active Hyperemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frei, B; Gokce, N; Holbrook, M; Keaney, JF; Leaf, C; Vita, JA | 1 |
| Bogaty, P; Kingma, JG; Plante, S | 1 |
1 trial(s) available for thiazolidines and Active Hyperemia
| Article | Year |
|---|---|
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.
Topics: Administration, Oral; Aged; Arteriosclerosis; Blood Flow Velocity; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Cysteine; Double-Blind Method; Endothelium, Vascular; Female; Glutathione; Heart Rate; Humans; Hyperemia; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Oxidation-Reduction; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Triglycerides; Ultrasonography | 1998 |
1 other study(ies) available for thiazolidines and Active Hyperemia
| Article | Year |
|---|---|
Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion.
Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Flow Cytometry; Heart; Hemodynamics; Hyperemia; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines | 2000 |